Similar articles for PMID: 26361173

Year	Number of Results
1993	2
1994	1
1996	3
1997	3
1998	3
2000	2
2001	3
2002	3
2003	1
2004	1
2005	3
2006	1
2007	3
2008	6
2009	9
2010	4
2011	4
2012	9
2013	12
2014	13
2015	27
2016	12
2017	25
2018	22
2019	23
2020	32
2021	18
2022	20
2023	5
2024	0

1

Risk of HIV and Hepatitis B and C Over Time Among Men Who Inject Image and Performance Enhancing Drugs in England and Wales: Results From Cross-Sectional Prevalence Surveys, 1992-2013.

Hope VD, Harris R, McVeigh J, Cullen KJ, Smith J, Parry JV, DeAngelis D, Ncube F. Hope VD, et al. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):331-7. doi: 10.1097/QAI.0000000000000835. J Acquir Immune Defic Syndr. 2016. PMID: 26361173 Free PMC article.

2

Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.

Semá Baltazar C, Boothe M, Kellogg T, Ricardo P, Sathane I, Fazito E, Raymond HF, Temmerman M, Luchters S. Semá Baltazar C, et al. BMC Public Health. 2020 Jun 3;20(1):851. doi: 10.1186/s12889-020-09012-w. BMC Public Health. 2020. PMID: 32493347 Free PMC article.

3

Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).

Scheibe A, Young K, Versfeld A, Spearman CW, Sonderup MW, Prabdial-Sing N, Puren A, Hausler H. Scheibe A, et al. BMC Infect Dis. 2020 Sep 7;20(1):655. doi: 10.1186/s12879-020-05359-y. BMC Infect Dis. 2020. PMID: 32894072 Free PMC article.

4

Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.

van Beek I, Chronister KJ. van Beek I, et al. Int J Drug Policy. 2015 Sep;26(9):868-74. doi: 10.1016/j.drugpo.2015.05.009. Epub 2015 Jun 3. Int J Drug Policy. 2015. PMID: 26118797

5

Risk and blood-borne virus testing among men who inject image and performance enhancing drugs, Sydney, Australia.

Rowe R, Berger I, Yaseen B, Copeland J. Rowe R, et al. Drug Alcohol Rev. 2017 Sep;36(5):658-666. doi: 10.1111/dar.12467. Epub 2017 Feb 28. Drug Alcohol Rev. 2017. PMID: 28244160

6

Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.

Yuan JM, Croxford S, Viviani L, Emanuel E, Phipps E, Desai M. Yuan JM, et al. Int J Drug Policy. 2022 Nov;109:103821. doi: 10.1016/j.drugpo.2022.103821. Epub 2022 Aug 20. Int J Drug Policy. 2022. PMID: 35994940 Free article.

7

Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15.

Glass R, Hope VD, Njoroge J, Edmundson C, Smith J, McVeigh J, Parry J, Desai M. Glass R, et al. Drug Alcohol Depend. 2019 Feb 1;195:40-44. doi: 10.1016/j.drugalcdep.2018.11.021. Epub 2018 Dec 14. Drug Alcohol Depend. 2019. PMID: 30580202

8

High regional variability of HIV, HCV and injecting risks among people who inject drugs in Poland: comparing a cross-sectional bio-behavioural study with case-based surveillance.

Rosińska M, Sierosławski J, Wiessing L. Rosińska M, et al. BMC Infect Dis. 2015 Feb 21;15:83. doi: 10.1186/s12879-015-0828-9. BMC Infect Dis. 2015. PMID: 25879904 Free PMC article.

9

Epidemiology of HIV and hepatitis C infection among women who inject drugs in Northeast India: a respondent-driven sampling study.

McFall AM, Solomon SS, Lucas GM, Celentano DD, Srikrishnan AK, Kumar MS, Mehta SH. McFall AM, et al. Addiction. 2017 Aug;112(8):1480-1487. doi: 10.1111/add.13821. Epub 2017 Apr 18. Addiction. 2017. PMID: 28317210 Free PMC article.

10

Factors associated with hepatitis C and HIV testing uptake among men who inject image and performance enhancing drugs.

Hope VD, McVeigh J, Begley E, Glass R, Edmundson C, Heinsbroek E, Kean J, Campbell J, Whitfield M, Morgan G, Acreman D, Smith J. Hope VD, et al. Drug Alcohol Rev. 2021 May;40(4):586-596. doi: 10.1111/dar.13198. Epub 2020 Nov 8. Drug Alcohol Rev. 2021. PMID: 33164293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

242 results

Results by year